Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin for Early Patency of AVF in ESRD
NCT02493504Phase 4Completed
- Start
- Jan 2011
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 4 trial of heparin in arteriovenous fistula thrombosis (AVFT). Started Jan 2011; status: completed.
02
Drugs
heparin
03
Conditions
arteriovenous fistula thrombosis (AVFT)
Beyond the preview
Go deeper on NCT02493504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493504.